Westborough, MA, United States of America

Harold Scott Wilkinson

USPTO Granted Patents = 20 



Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 105(Granted Patents)


Location History:

  • Marlborough, MA (US) (2004 - 2007)
  • Westboro, MA (US) (2019 - 2022)
  • Westborough, MA (US) (2012 - 2023)

Company Filing History:


Years Active: 2004-2024

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Harold Scott Wilkinson: Innovations and Patents in Pharmaceuticals

Introduction:

Harold Scott Wilkinson is an esteemed inventor and researcher based in Westborough, Massachusetts, USA. With an impressive portfolio of 16 patents, Wilkinson has made significant contributions to the pharmaceutical industry. This article aims to explore his latest patents, highlight his career achievements, and shed light on his collaborations within the field.

Latest Patents:

Wilkinson's latest patents revolve around crystal forms and production methods of various pharmaceutical compounds. One notable invention is the creation of crystalline forms of (S)-(-)-amisulpride and (R)-(+)-amisulpride, along with the development of solvates and methods for their production. This innovative work opens avenues for enhanced drug delivery and potential improvements in therapeutic outcomes.

Another significant patent from Wilkinson is related to nonracemic mixtures of (R)-amisulpride and (S)-amisulpride, focusing on compositions where the concentration of (R)-amisulpride exceeds that of (S)-amisulpride. These compositions hold great promise in treating various diseases and disorders, offering potential advancements in dosage regimens and formulation development. Additionally, this patent emphasizes the use of polymorphs of enantiomeric amisulpride in different formulations.

Career Highlights:

Throughout his illustrious career, Harold Scott Wilkinson has been affiliated with Sunovion Pharmaceuticals Inc., a prominent player in the industry. Sunovion Pharmaceuticals Inc. is a leading global pharmaceutical company known for its commitment to research, development, and delivery of innovative solutions for patients worldwide.

Collaborations:

Wilkinson has had the opportunity to collaborate with esteemed colleagues, such as John R. Snoonian and Seth C. Hopkins. These collaborations have likely played a crucial role in advancing research, knowledge exchange, and the development of novel pharmaceutical solutions. By working alongside fellow experts within the field, Wilkinson has benefited from their expertise, fostering an environment of innovation and collective success.

Conclusion:

Harold Scott Wilkinson's significant contributions to the pharmaceutical industry are reflected in his extensive patent portfolio and his work at Sunovion Pharmaceuticals Inc. His focus on crystal forms for amisulpride and nonracemic mixtures highlights his dedication to developing novel solutions with potential therapeutic benefits. Collaborations with accomplished professionals like John R. Snoonian and Seth C. Hopkins have further enhanced Wilkinson's contributions, emphasizing the importance of teamwork and knowledge exchange in driving innovation forward. As a respected inventor and researcher, Wilkinson continues to make strides in the field of pharmaceuticals, inspiring others and shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…